Erythroblastosis Fetalis
- 16 September 1954
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 251 (12) , 453-459
- https://doi.org/10.1056/nejm195409162511201
Abstract
STILLBIRTH remains a major problem in erythroblastosis fetalis caused by Rh incompatibility, since about 20 per cent of the fetuses in these cases die in utero. The ultimate failure of all preventive methods that have been enthusiastically advocated in the past1 2 3 4 illustrates the difficulty of interpreting the results of therapy in this condition. This difficulty arises from two principal factors: the great variability and unpredictability of erythroblastosis, and the fact that any method of treatment tends to result in a selected series of cases that may not be comparable with a previous, untreated series.This study presents a nine-year survey . . .Keywords
This publication has 8 references indexed in Scilit:
- CORTISONE THERAPY IN Rh INCOMPATIBILITYJAMA, 1954
- CORTISONE THERAPY IN Rh INCOMPATIBILITIESJAMA, 1954
- CORTISONE AND ERYTHROBLASTOSIS - EVALUATION OF MANAGEMENT OF PREGNANCY IN THE RH-IMMUNIZED WOMAN1954
- A preliminary report on a new concept in the treatment of Rh-negative pregnant womenAmerican Journal of Obstetrics and Gynecology, 1950
- The use of methionine in obstetricsAmerican Journal of Obstetrics and Gynecology, 1949
- The treatment of erythroblastosis fetalis with Rh haptenAmerican Journal of Obstetrics and Gynecology, 1948
- On the Prophylaxis of Hemolytic Disease of the NewbornAmerican Journal of Obstetrics and Gynecology, 1947